Biorasi Welcomes Scott Nenninger as Chief Financial Officer
Biorasi is proud to announce the appointment of Scott Nenninger to the position of Chief Financial Officer (CFO)
Biorasi Completes Rare Nephrology Trial During COVID-19
Biorasi has completed subject visits under Part A in a rare disease nephropathy study during the peak of the COVID-19 outbreak.
Biorasi Begins Second COVID-19 Clinical Trial of 2020
Biorasi is proud to announce the start of a second COVID-19 clinical trial for 2020. The trial will be executed in Russia and Ukraine and will focus on the efficacy of prophylaxis medication for maintaining the health and safety of healthcare personnel treating patients with the coronavirus.
Biorasi Starts First COVID-19 Clinical Trial in May 2020
Biorasi is proud to announce the initiation of the company’s first COVID-19 clinical trial in May 2020. The U.S.-based trial will focus on the treatment for lung injuries caused by the COVID-19 virus.
Biorasi Loves Clinical Sites
To our #sitepartners on the front lines, from all of us at Biorasi, thank you for everything you do to bring critical treatments to patients as we face #COVID19 together.
Unflattening the Curve: Minimize the Impact to Patients Who Depend on Your Successful Clinical Trial
In this time of uncertainty caused by the COVID-19 pandemic, the importance of delivering new treatments to patients as quickly as possible has never been more vital. Without a proactive and comprehensive strategy in place to manage clinical trials over the coming weeks and maybe months, consequences may be severe –especially for those that need the treatment the most.
The Focus is Digital: Biorasi Reports from Molecular Med Tri-Con 2020
Digital technology’s presence in the healthcare industry continues to grow, expanding across diagnostic and therapeutic treatments in precision medicine. Biorasi was on-site to witness these advancements and innovations at this year’s Molecular Med Tri-Con.
The Evolution of Digital Therapeutics and the Need for Clinical Evidence: Lessons Learned from DTx West 2020
With digital therapeutics experiencing an evolution, Biorasi was on hand at DTx West 2020 to highlight the importance of evidence as a differentiator in clinical trials. Read more about our event experience >>
